Cargando…
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors
PURPOSE: The use of electronic patient-reported outcome (ePRO) data in routine care has been tied to direct patient benefits such as improved quality of care and symptom control and even overall survival. The modes of action behind such benefits are seldom described in detail. Here, we describe the...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363070/ https://www.ncbi.nlm.nih.gov/pubmed/37480546 http://dx.doi.org/10.1007/s00520-023-07934-w |
_version_ | 1785076560953344000 |
---|---|
author | da Silva Lopes, André Manuel Colomer-Lahiguera, Sara Darnac, Célia Giacomini, Stellio Bugeia, Sébastien Gutknecht, Garance Spurrier-Bernard, Gilliosa Aedo-Lopez, Veronica Mederos, Nuria Latifyan, Sofiya Addedo, Alfredo Michielin, Olivier Eicher, Manuela |
author_facet | da Silva Lopes, André Manuel Colomer-Lahiguera, Sara Darnac, Célia Giacomini, Stellio Bugeia, Sébastien Gutknecht, Garance Spurrier-Bernard, Gilliosa Aedo-Lopez, Veronica Mederos, Nuria Latifyan, Sofiya Addedo, Alfredo Michielin, Olivier Eicher, Manuela |
author_sort | da Silva Lopes, André Manuel |
collection | PubMed |
description | PURPOSE: The use of electronic patient-reported outcome (ePRO) data in routine care has been tied to direct patient benefits such as improved quality of care and symptom control and even overall survival. The modes of action behind such benefits are seldom described in detail. Here, we describe the development of a model of care leveraging ePRO data to monitor and manage symptoms of patients treated with immune checkpoint inhibitors. METHODS: Development was split into four stages: (1) identification of an underlying theoretical framework, (2) the selection of an ePRO measure (ePROM), (3) the adaptation of an electronic application to collect ePRO data, and (4) the description of an ePRO-oriented workflow. The model of care is currently evaluated in a bicentric longitudinal randomized controlled phase II trial, the IePRO study. RESULTS: The IePRO model of care is grounded in the eHealth Enhanced Chronic Care Model. Patients are prompted to report symptoms using an electronic mobile application. Triage nurses are alerted, review the reported symptoms, and contact patients in case of a new or worsening symptom. Nurses use the UKONS 24-hour telephone triage tool to issue patient management recommendations to the oncology team. Adapted care coordinating procedures facilitate team collaboration and provide patients with timely feedback. CONCLUSION: This report clarifies how components of care are created and modified to leverage ePRO to enhance care. The model describes a workflow that enables care teams to be proactive and provide patients with timely, multidisciplinary support to manage symptoms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-023-07934-w. |
format | Online Article Text |
id | pubmed-10363070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-103630702023-07-24 Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors da Silva Lopes, André Manuel Colomer-Lahiguera, Sara Darnac, Célia Giacomini, Stellio Bugeia, Sébastien Gutknecht, Garance Spurrier-Bernard, Gilliosa Aedo-Lopez, Veronica Mederos, Nuria Latifyan, Sofiya Addedo, Alfredo Michielin, Olivier Eicher, Manuela Support Care Cancer Research PURPOSE: The use of electronic patient-reported outcome (ePRO) data in routine care has been tied to direct patient benefits such as improved quality of care and symptom control and even overall survival. The modes of action behind such benefits are seldom described in detail. Here, we describe the development of a model of care leveraging ePRO data to monitor and manage symptoms of patients treated with immune checkpoint inhibitors. METHODS: Development was split into four stages: (1) identification of an underlying theoretical framework, (2) the selection of an ePRO measure (ePROM), (3) the adaptation of an electronic application to collect ePRO data, and (4) the description of an ePRO-oriented workflow. The model of care is currently evaluated in a bicentric longitudinal randomized controlled phase II trial, the IePRO study. RESULTS: The IePRO model of care is grounded in the eHealth Enhanced Chronic Care Model. Patients are prompted to report symptoms using an electronic mobile application. Triage nurses are alerted, review the reported symptoms, and contact patients in case of a new or worsening symptom. Nurses use the UKONS 24-hour telephone triage tool to issue patient management recommendations to the oncology team. Adapted care coordinating procedures facilitate team collaboration and provide patients with timely feedback. CONCLUSION: This report clarifies how components of care are created and modified to leverage ePRO to enhance care. The model describes a workflow that enables care teams to be proactive and provide patients with timely, multidisciplinary support to manage symptoms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-023-07934-w. Springer Berlin Heidelberg 2023-07-22 2023 /pmc/articles/PMC10363070/ /pubmed/37480546 http://dx.doi.org/10.1007/s00520-023-07934-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research da Silva Lopes, André Manuel Colomer-Lahiguera, Sara Darnac, Célia Giacomini, Stellio Bugeia, Sébastien Gutknecht, Garance Spurrier-Bernard, Gilliosa Aedo-Lopez, Veronica Mederos, Nuria Latifyan, Sofiya Addedo, Alfredo Michielin, Olivier Eicher, Manuela Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors |
title | Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors |
title_full | Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors |
title_fullStr | Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors |
title_full_unstemmed | Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors |
title_short | Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors |
title_sort | development of an ehealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363070/ https://www.ncbi.nlm.nih.gov/pubmed/37480546 http://dx.doi.org/10.1007/s00520-023-07934-w |
work_keys_str_mv | AT dasilvalopesandremanuel developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT colomerlahiguerasara developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT darnaccelia developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT giacoministellio developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT bugeiasebastien developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT gutknechtgarance developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT spurrierbernardgilliosa developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT aedolopezveronica developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT mederosnuria developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT latifyansofiya developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT addedoalfredo developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT michielinolivier developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors AT eichermanuela developmentofanehealthenhancedmodelofcareforthemonitoringandmanagementofimmunerelatedadverseeventsinpatientstreatedwithimmunecheckpointinhibitors |